Butterfly Network, Inc.
$5.49
▲
0.49%
2026-04-21 05:38:00
www.butterflynetwork.com
NYQ: BFLY
Explore Butterfly Network, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.39 B
Current Price
$5.49
52W High / Low
$5.62 / $1.32
Stock P/E
—
Book Value
$0.77
Dividend Yield
—
ROCE
-37.34%
ROE
-42.25%
Face Value
—
EPS
$-0.31
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
220
Beta
2.22
Debt / Equity
10.41
Current Ratio
3.83
Quick Ratio
2.88
Forward P/E
-41.1
Price / Sales
10.72
Enterprise Value
$916.45 M
EV / EBITDA
-16.92
EV / Revenue
9.39
Rating
Strong Buy
Target Price
$5.56
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Baird Medical Investment Holdings Limited | $1.79 | 55.75 | $64.64 M | — | 35.34% | -8.03% | $7.26 / $0.76 | $1.34 |
| 2. | Bruker Corporation | $41.1 | — | $6.23 B | 0.49% | 4.76% | -0.38% | $56.22 / $28.53 | $16.15 |
| 3. | Koninklijke Philips N.V. | $28.41 | 25.52 | $27.66 B | 0% | 7.46% | 7.82% | $27.7 / $19.09 | $13.43 |
| 4. | Accuray Incorporated | $0.46 | — | $52.79 M | — | 2.82% | -70.32% | $2.1 / $0.33 | $0.45 |
| 5. | InfuSystem Holdings, Inc. | $10.79 | 32.21 | $213.43 M | — | 14.83% | 11.54% | $11.04 / $4.66 | $2.84 |
| 6. | Integra LifeSciences Holdings Corporation | $11.16 | — | $875.54 M | — | 0.57% | -39.9% | $17.54 / $8.7 | $13.4 |
| 7. | Tactile Systems Technology, Inc. | $25.52 | 30.42 | $580.59 M | — | 12.57% | 8.77% | $37.77 / $8.61 | $9.76 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 31.51 M | 21.49 M | 23.38 M | 21.23 M | 22.35 M | — |
| Operating Profit | -16.71 M | -35.13 M | -16.1 M | -18.47 M | -17.31 M | — |
| Net Profit | -15.29 M | -33.97 M | -13.83 M | -13.97 M | -18.1 M | — |
| EPS in Rs | -0.07 | -0.15 | -0.06 | -0.06 | -0.08 | -0.08 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 97.61 M | 82.06 M | 65.9 M | 73.39 M |
| Operating Profit | -86.42 M | -74.41 M | -145.61 M | -193.02 M |
| Net Profit | -77.06 M | -72.49 M | -133.7 M | -168.72 M |
| EPS in Rs | -0.34 | -0.32 | -0.59 | -0.74 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 296.53 M | 256.08 M | 304.27 M | 417.57 M |
| Total Liabilities | 100.55 M | 87.25 M | 84.22 M | 92.21 M |
| Equity | 195.98 M | 168.83 M | 220.05 M | 325.36 M |
| Current Assets | 249.1 M | 192.61 M | 231.26 M | 357.14 M |
| Current Liabilities | 65.12 M | 48.22 M | 44.27 M | 51.33 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -12.7 M | -41.71 M | -98.82 M | -169.12 M |
| Investing CF | -3.35 M | -2.66 M | 70.41 M | -93.78 M |
| Financing CF | 77.76 M | -1.5 M | 0.23 M | 2.88 M |
| Free CF | -16.05 M | -44.4 M | -104.6 M | -187.42 M |
| Capex | -3.35 M | -2.69 M | -5.78 M | -18.3 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 18.96% | 24.52% | -10.21% | — |
| Earnings Growth % | -6.31% | 45.78% | 20.76% | — |
| Profit Margin % | -78.95% | -88.34% | -202.88% | -229.9% |
| Operating Margin % | -88.53% | -90.68% | -220.96% | -263.01% |
| Gross Margin % | 46.85% | 59.51% | 25.58% | 53.77% |
| EBITDA Margin % | -69.03% | -74.24% | -186.71% | -221.75% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.